Dynavax Technologies Corporation (DVAX)

Cash conversion cycle

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Days of inventory on hand (DOH) days 517.13 509.27 508.12 485.97 387.72 151.60 115.98 88.89 82.77 144.78 104.89 152.71 128.98 237.06 663.48 741.63 1,671.21 1,477.65 1,188.88 879.21
Days of sales outstanding (DSO) days
Number of days of payables days
Cash conversion cycle days 517.13 509.27 508.12 485.97 387.72 151.60 115.98 88.89 82.77 144.78 104.89 152.71 128.98 237.06 663.48 741.63 1,671.21 1,477.65 1,188.88 879.21

December 31, 2024 calculation

Cash conversion cycle = DOH + DSO – Number of days of payables
= 517.13 + — – —
= 517.13

The cash conversion cycle of Dynavax Technologies Corporation has shown significant fluctuations over the past few years. The company's cash conversion cycle, which measures the time it takes for a company to convert its investments in inventory and other resources into cash, has ranged from as high as 1,671.21 days to as low as 82.77 days.

In analyzing the trend, it is evident that there has been a general improvement in the cash conversion cycle over recent periods, with a notable decrease in the cycle duration. The trend indicates that the company has become more efficient in managing its working capital and converting its assets into cash.

However, it is important to highlight the volatility in the cash conversion cycle, as seen by fluctuations observed throughout the data timeline. This volatility may be indicative of changes in the company's operating cycle efficiency, management practices, or fluctuations in the industry and market conditions.

Overall, the decreasing trend in the cash conversion cycle suggests that Dynavax Technologies Corporation has been making improvements in its working capital management and operational efficiency, which is a positive indicator for the company's financial health and performance.